| 摘要 |
The invention provides a treatment of mesothelioma, especially malignant pleural mesothelioma, using an estrogen receptor &bgr; subtype (ER&bgr;) agonist, wherein the treatment comprises administering the ER&bgr; agonist to the patient, and then after a time, t, of up to 24 hours; administering a platinum-containing anti-cancer drug to the patient. The invention also provides an ER&bgr; agonist and a platinum-containing anti-cancer drug for use in the treatment of mesothelioma in a patient, wherein the treatment comprises administering the ER&bgr; agonist to the patient, and then after a time, t, of up to 24 hours, administering the platinum- containing anti-cancer drug to the patient; and a kit comprising a platinum-containing anti- cancer drug and an ER&bgr; agonist. |
